Subsequent Events - Additional Information (Detail) - Subsequent Event - Merger Agreement [Member] - Pandologic Ltd [Member] shares in Millions, $ in Millions |
Jul. 21, 2021
USD ($)
shares
|
---|---|
Subsequent Event [Line Items] | |
Total consideration | $ 150 |
Merger consideration upfront payment in cash | 50 |
Merger, earnout consideration payable | 65 |
Common Stock | |
Subsequent Event [Line Items] | |
Merger consideration transferred equity interests issued | $ 35 |
Merger consideration equity interest issued number of shares | shares | 1.7 |
X | ||||||||||
- Definition Number of shares of equity interests issued or issuable to acquire entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. No definition available.
|
X | ||||||||||
- Definition Business combination earnout consideration payable. No definition available.
|
X | ||||||||||
- Definition Business combination upfront cash payment. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|